Back to Search
Start Over
Survivin in Breast Cancer: A Review.
- Source :
-
Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2022 Sep; Vol. 26 (9), pp. 411-421. - Publication Year :
- 2022
-
Abstract
- Breast cancer is the most frequently diagnosed cancer in women and ranks second among causes for cancer-related death in women. Gene technology has led to the recognition that breast cancer is a heterogeneous disease composed of different biological subtypes, and genetic profiling enables the response to chemotherapy to be predicted. This fact emphasizes the importance of selecting sensitive diagnostic and prognostic markers in the early disease stage and more efficient targeted treatments for this disease. One such prognostic marker appears to be survivin. Many studies have shown that survivin is strongly expressed in different types of cancers. Its overexpression has been demonstrated in breast cancer, and high activity of the survivin gene has been associated with a poor prognosis and worse survival rates.
Details
- Language :
- English
- ISSN :
- 1945-0257
- Volume :
- 26
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Genetic testing and molecular biomarkers
- Publication Type :
- Academic Journal
- Accession number :
- 36166738
- Full Text :
- https://doi.org/10.1089/gtmb.2021.0286